AAPL   321.04 (+0.92%)
MSFT   182.45 (+0.35%)
FB   228.95 (-0.08%)
AMZN   2,418.77 (+0.35%)
NVDA   344.58 (+1.05%)
CGC   21.16 (+6.33%)
BABA   200.27 (-0.45%)
MU   47.78 (-3.40%)
GE   7.09 (-2.88%)
TSLA   817.42 (-0.34%)
AMD   52.78 (+0.06%)
ACB   16.30 (+6.54%)
GILD   75.54 (+0.85%)
DIS   119.16 (-1.95%)
NFLX   420.24 (+0.08%)
BAC   25.22 (-2.93%)
BA   154.46 (+3.30%)
AAPL   321.04 (+0.92%)
MSFT   182.45 (+0.35%)
FB   228.95 (-0.08%)
AMZN   2,418.77 (+0.35%)
NVDA   344.58 (+1.05%)
CGC   21.16 (+6.33%)
BABA   200.27 (-0.45%)
MU   47.78 (-3.40%)
GE   7.09 (-2.88%)
TSLA   817.42 (-0.34%)
AMD   52.78 (+0.06%)
ACB   16.30 (+6.54%)
GILD   75.54 (+0.85%)
DIS   119.16 (-1.95%)
NFLX   420.24 (+0.08%)
BAC   25.22 (-2.93%)
BA   154.46 (+3.30%)
AAPL   321.04 (+0.92%)
MSFT   182.45 (+0.35%)
FB   228.95 (-0.08%)
AMZN   2,418.77 (+0.35%)
NVDA   344.58 (+1.05%)
CGC   21.16 (+6.33%)
BABA   200.27 (-0.45%)
MU   47.78 (-3.40%)
GE   7.09 (-2.88%)
TSLA   817.42 (-0.34%)
AMD   52.78 (+0.06%)
ACB   16.30 (+6.54%)
GILD   75.54 (+0.85%)
DIS   119.16 (-1.95%)
NFLX   420.24 (+0.08%)
BAC   25.22 (-2.93%)
BA   154.46 (+3.30%)
AAPL   321.04 (+0.92%)
MSFT   182.45 (+0.35%)
FB   228.95 (-0.08%)
AMZN   2,418.77 (+0.35%)
NVDA   344.58 (+1.05%)
CGC   21.16 (+6.33%)
BABA   200.27 (-0.45%)
MU   47.78 (-3.40%)
GE   7.09 (-2.88%)
TSLA   817.42 (-0.34%)
AMD   52.78 (+0.06%)
ACB   16.30 (+6.54%)
GILD   75.54 (+0.85%)
DIS   119.16 (-1.95%)
NFLX   420.24 (+0.08%)
BAC   25.22 (-2.93%)
BA   154.46 (+3.30%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BELLUS HealthClinuvel PharmaceuticalsPolynovoConcordia InternationalOxford BioMedica
SymbolTSE:BLUASX:CUVASX:PNVTSE:CXRLON:OXB
Price Information
Current PriceC$14.17A$23.00A$2.49N/AGBX 763.03
52 Week RangeBuyN/AN/AN/ABuy
Beat the Market™ Rank
Overall Score0.61.01.10.71.7
Analysis Score0.00.00.00.02.4
Community Score2.42.42.72.42.4
Dividend Score0.02.50.00.00.0
Ownership Score0.00.03.00.03.0
Earnings & Valuation Score0.60.00.01.30.6
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/ABuy
Consensus Price TargetN/AN/AN/AN/AGBX 910
% Upside from Price TargetN/AN/AN/AN/A19.26% upside
Trade Information
Market CapC$874.18 million$1.14 billion$1.65 billionC$1.22 billion£585.05 million
BetaN/AN/AN/AN/AN/A
Average Volume111,206N/AN/A4,0546,890,000
Sales & Book Value
Annual RevenueC$35,000.00$32.04 million$18.56 millionC$569.62 million£64.06 million
Price / Sales24,408.0335.4788.710.009.17
CashflowC$1.95 per shareA$1.19 per shareA$0.01 per shareN/AGBX 35.61 per share
Price / Cash7.2819.36207.505.8521.43
Book ValueC$2.08 per shareA$1.20 per shareA$0.04 per shareC$6.08 per shareGBX 104.50 per share
Price / Book6.8119.1767.300.000.07
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC($0.73)A$0.30A($0.01)C$351.68GBX (11.60)
Trailing P/E RatioN/A75.91N/A0.07N/A
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AA$0.03N/AN/AN/A
Dividend YieldN/A0.13%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A9.90%N/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.21%0.53%9.87%457.02%11.09%
Current Ratio12.38%15.38%6.28%2.10%1.97%
Quick Ratio11.99%14.70%4.56%1.66%1.88%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees10N/A41N/A432
Shares Outstanding60.29 million49.41 million661.09 million48.91 million76.98 million
Next Earnings Date8/13/2020 (Estimated)N/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.